GPI-0100 is Avantogen’s lead adjuvanat-immunopotentiator, a key component of vaccines for boosting the immune response. The GPI-0100 adjuvant, which has been shown to significantly enhance the immune response with a variety of vaccines, has been shown to have good overall performance characteristics on safety and efficacy.

Synonyms: GPI-0100

This is just here as a test because I lose it

Term information

database cross reference
  • PubChem Substance:347910317
hasDbXref

PubChem Substance:347910317

inScheme

https://identifiers.org/drugbank

label

GPI-0100

Term relations

Subclass of: